Hospital Recruiting Patients for Study on New Alzheimer’s Treatment
(posted August 6, 2009)
The Alzheimer’s Disease and Memory Disorders Center at Rhode Island Hospital is currently recruiting patients to take part in a multi-center study testing a new investigational drug to determine if it can slow the progression of Alzheimer’s disease.
More than 800 volunteers in 250 study sites across the United States and Canada will take part in the trial, known as the ICARA study. The study will last up to 83 weeks and all study-related procedures and medication will be provided at no cost to participants. A medical team of a physician, nurse, neuropsychologist and study coordinator will monitor each participant during the study. Participants will be compensated for their travel.
To be eligible, participants must be between the ages of 50 and 88, have a diagnosis of probable Alzheimer’s disease and have a caregiver who is willing to be involved in the study.
The trial will be led locally by Brian R. Ott, MD. He is a neurologist and the director of the Alzheimer’s Disease and Memory Disorders Center as well as a professor of medicine at The Warren Alpert Medical School of Brown University. He is board certified in neurology, geriatric medicine and internal medicine.
The Alzheimer’s Disease and Memory Disorders Center is located on the sixth floor of the Ambulatory Patient Center (APC) at Rhode Island Hospital. Free valet parking service is available at the APC entrance.
For more information, call research coordinator Michele Astphan at 401-444-2484.